Literature DB >> 11591850

Sleep-disordered breathing and respiratory failure in acid maltase deficiency.

U Mellies1, R Ragette, C Schwake, M Baethmann, T Voit, H Teschler.   

Abstract

BACKGROUND: Sleep-disordered breathing (SDB) and respiratory failure (RF) are complications of acid maltase deficiency (AMD), a rare hereditary myopathy.
OBJECTIVE: To define the relationship between lung and respiratory muscle function, to establish incidence and patterns of SDB, and to determine daytime predictors of SDB.
METHODS: Sitting and supine lung and respiratory muscle function tests were obtained in 27 subjects with juvenile and adult AMD (aged 39 +/- 19 years) and compared with outcomes of polysomnography.
RESULTS: Ventilatory restriction was present in 17/27 subjects. Inspiratory vital capacity (IVC) correlated (p < 0.005) with peak inspiratory muscle pressure (PIP, R = 0.61), respiratory muscle strain (P(0.1)/P(0.1max), R = -0.68), and gas exchange by day (PaO(2): R = 0.71; PaCO(2): R = -0.64) and night (SaO(2): R = 0.73; P(tc)CO(2): R = -0.75). Diaphragm weakness (DW) was present in 13 subjects, 10 of whom had hypercapnic RF (PaCO(2) 65 +/- 7 mm Hg), and was associated with longer disease course. SDB was found in 13 subjects, 12 with DW. It was characterized by REM-sleep hypopneas that, as ventilatory restriction worsened, were complemented by hypoventilation (P(tc)CO(2) > 50 mm Hg) first in REM sleep, then in non-REM sleep (p < 0.005). SDB was predicted by DW (sensitivity 80%, specificity 86%) and nocturnal hypoventilation by IVC < 40% (sensitivity 80%, specificity 93%). Noninvasive ventilation, instituted for daytime respiratory failure or nocturnal hypoventilation, normalized daytime and nocturnal gas exchange (p < 0.005).
CONCLUSION: Vital capacity correlates with respiratory muscle function in AMD. Diaphragm weakness is the major cause of SDB and RF. SDB and nocturnal hypoventilation are predictable from daytime function tests.

Entities:  

Mesh:

Year:  2001        PMID: 11591850     DOI: 10.1212/wnl.57.7.1290

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

Review 1.  [Diagnosis and therapy of late onset Pompe disease].

Authors:  A Schüller; C Kornblum; M Deschauer; M Vorgerd; B Schrank; E Mengel; Z Lukacs; D Gläser; P Young; U Plöckinger; B Schoser
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

2.  A 54-year-old man with acute onset orthopnea and sleep-related hypoxia.

Authors:  Praveen Jinnur; Neeraj Kumar; Robert Vassallo; Erik K St Louis
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

3.  Inspiratory Muscle Training in Late-Onset Pompe Disease: The Effects on Pulmonary Function Tests, Quality of Life, and Sleep Quality.

Authors:  Goksen Kuran Aslan; Burcu Ersoz Huseyinsinoglu; Piraye Oflazer; Nilgun Gurses; Esen Kiyan
Journal:  Lung       Date:  2016-04-22       Impact factor: 2.584

Review 4.  The natural course of non-classic Pompe's disease; a review of 225 published cases.

Authors:  Léon P F Winkel; Marloes L C Hagemans; Pieter A van Doorn; M Christa B Loonen; Wim J C Hop; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2005-08       Impact factor: 4.849

5.  Lipid-storage myopathy and respiratory insufficiency due to ETFQO mutations in a patient with late-onset multiple acyl-CoA dehydrogenation deficiency.

Authors:  R K J Olsen; M Pourfarzam; A A M Morris; R C Dias; I Knudsen; B S Andresen; N Gregersen; S E Olpin
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

6.  Combined general and epidural anesthesia for major abdominal surgery in a patient with Pompe disease.

Authors:  Won Sung Kim; Ah Reum Cho; Jung Min Hong; Eun Soo Kim; Sung Chun Park; Ji Young Yoon; Tae Kyun Kim
Journal:  J Anesth       Date:  2010-07-09       Impact factor: 2.078

Review 7.  Neuromuscular disorders and sleep.

Authors:  Ibrahim Oztura; Christian Guilleminault
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

8.  Systemic Delivery of AAVB1-GAA Clears Glycogen and Prolongs Survival in a Mouse Model of Pompe Disease.

Authors:  Allison M Keeler; Marina Zieger; Sophia H Todeasa; Angela L McCall; Jennifer C Gifford; Samantha Birsak; Sourav R Choudhury; Barry J Byrne; Miguel Sena-Esteves; Mai K ElMallah
Journal:  Hum Gene Ther       Date:  2018-07-25       Impact factor: 5.695

9.  Sleep-Disordered Breathing and Effects of Noninvasive Ventilation in Patients with Late-Onset Pompe Disease.

Authors:  Matthias Boentert; Bianca Dräger; Christian Glatz; Peter Young
Journal:  J Clin Sleep Med       Date:  2016-12-15       Impact factor: 4.062

10.  Patterns and predictors of sleep disordered breathing in primary myopathies.

Authors:  R Ragette; U Mellies; C Schwake; T Voit; H Teschler
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.